5
6
1 Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2012;DOI 10.1002/art.37715.
2
3
Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129–34.
Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.
4
7
8
9
10
11
12
13
14
15
Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology Classification Criteria in the Diagnosis of Vasculitis. Ann Intern Med. 1998;129:345–52.
Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002;287:92–101.
Maldini C, Dépinay-Dhellemmes C, Tra TT, et al. Limited value of temporal artery ultrasonography examinations for diagnosis of giant cell arteritis: analysis of 77 subjects. J Rheumatol. 2010;37:2326–30.
Arida A, Kyrianou M, Kanakis M, Sfikakis PP. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord. 2010;11:44.
Mahr A, Saba M, Kambouchner M, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?
Ann Rheum Dis. 2006;65:826–8.
Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology. 2008;47:96–101.
Reinhard M, Schmidt WA, Hetzel A, Bley TA. Imaging techniques for giant cell arteritis. Ultrasound and MRI. Z Rheumatol.
2009;68:108–16.
Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005;142:359–69.
Bley TA, Wieben O, Uhl M, et al. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporary artery. AJR Am J Roentgenol. 2005;184:283–7.
Bley TA, Markl M, Schelp M, et al. Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment. Rheumatology. 2008;47:65–7.
Mehrdad M, Hunder GG, Kirk A, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum . 2006;54: 3310–8 .
Villiger P. Tocilizumab bei Riesenzellenarteriitis. Rheuma Schweiz. 2012;5:13–5.

16
17
18
Nesher G, Berkun Y, Mates M, et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis . Arthritis Rheum. 2004;50:1332–7.
Mahr AD, Jover JA, Spiera RF, et al. Adjunctive methotrexate for treatment of giant cell arteriitis. An individual patient data meta-analysis. Arthritis Rheum. 2007;56:2789–97.
Seitz M, Reichenbach S, Bonel H, et al. Rapid induction of remission in large vessel vasculitis by IL-6 blockade. Swiss Med
Wkly. 2011;141:w13156.